SCHEMBL5111648

SCHEMBL5111648

CCOC(=O)c1cnc(-c2ccc(Cl)c(C)c2)nc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.53
ALDH1A1 P00352 6/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
MAPT P10636 4/20 0.50
LMNA P02545 4/20 0.50
MAPK1 P28482 1/20 0.50
ATM Q13315 1/20 0.50
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
POLB P06746 3/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
CSNK1D P48730 1/20 0.46
FOS P01100 3/20 0.45
JUN P05412 3/20 0.45
NFKB1 P19838 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5125886 0.89 ALDH1A1 (0.59) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5120810 0.89 ALDH1A1 (0.53) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5124459 0.83 ALDH1A1 (0.50) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL11785304 0.82 ALDH1A1 (0.60) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL4181661 0.82 ALDH1A1 (0.51) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5118340 0.82 CYP1A2 (0.64) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5298454 0.81 CYP1A2 (0.39) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL13406317 0.81 ALDH1A1 (0.58) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL5111120 0.81 ALDH1A1 (0.60) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL4849077 0.80 ALDH1A1 (0.76) CYP1A2ALDH1A1SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194598-A1 Pyrimidine Carboxylic Acid Derivatives and Use Thereof DPYD, TYMP, TYMS CYP1A2 933/4885ALDH1A1 489/4885SMN1; SMN2 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.